Royal Bank of Canada’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-2,358
| Closed | -$4K | – | 7396 |
|
2023
Q1 | $4K | Sell |
2,358
-3,494
| -60% | -$5.93K | ﹤0.01% | 6270 |
|
2022
Q4 | $6K | Buy |
5,852
+5,339
| +1,041% | +$5.47K | ﹤0.01% | 6237 |
|
2022
Q3 | $1K | Buy |
513
+276
| +116% | +$538 | ﹤0.01% | 6865 |
|
2022
Q2 | $1K | Sell |
237
-2,088
| -90% | -$8.81K | ﹤0.01% | 6808 |
|
2022
Q1 | $16K | Sell |
2,325
-4,540
| -66% | -$31.2K | ﹤0.01% | 6252 |
|
2021
Q4 | $58K | Buy |
6,865
+2,332
| +51% | +$19.7K | ﹤0.01% | 5766 |
|
2021
Q3 | $34K | Buy |
4,533
+1,975
| +77% | +$14.8K | ﹤0.01% | 5869 |
|
2021
Q2 | $17K | Buy |
2,558
+275
| +12% | +$1.83K | ﹤0.01% | 6156 |
|
2021
Q1 | $23K | Buy |
2,283
+1,304
| +133% | +$13.1K | ﹤0.01% | 5852 |
|
2020
Q4 | $7K | Buy |
979
+679
| +226% | +$4.86K | ﹤0.01% | 6001 |
|
2020
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 5860 |
|
2020
Q2 | $2K | Sell |
300
-1,849
| -86% | -$12.3K | ﹤0.01% | 5857 |
|
2020
Q1 | $10K | Buy |
2,149
+805
| +60% | +$3.75K | ﹤0.01% | 5342 |
|
2019
Q4 | $12K | Buy |
1,344
+1,044
| +348% | +$9.32K | ﹤0.01% | 5484 |
|
2019
Q3 | $1K | Hold |
300
| – | – | ﹤0.01% | 5884 |
|
2019
Q2 | $1K | Hold |
300
| – | – | ﹤0.01% | 5787 |
|
2019
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 5548 |
|
2018
Q4 | $1K | Sell |
300
-316
| -51% | -$1.05K | ﹤0.01% | 5710 |
|
2018
Q3 | $4K | Sell |
616
-205
| -25% | -$1.33K | ﹤0.01% | 5752 |
|
2018
Q2 | $6K | Sell |
821
-979
| -54% | -$7.16K | ﹤0.01% | 5421 |
|
2018
Q1 | $40K | Buy |
1,800
+1,453
| +419% | +$32.3K | ﹤0.01% | 4554 |
|
2017
Q4 | $5K | Sell |
347
-990
| -74% | -$14.3K | ﹤0.01% | 5329 |
|
2017
Q3 | $21K | Buy |
1,337
+1,257
| +1,571% | +$19.7K | ﹤0.01% | 5185 |
|
2017
Q2 | $1K | Sell |
80
-320
| -80% | -$4K | ﹤0.01% | 5700 |
|
2017
Q1 | $9K | Buy |
+400
| New | +$9K | ﹤0.01% | 5341 |
|